Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type 2 Diabetes Mellitus and Peripheral Artery DiseaseSubodh Verma,C. David Mazer,Mohammed Al-Omran,Silvio E. Inzucchi,David Fitchett,Uwe Hehnke,Jyothis T. George,Bernard ZinmanCirculation(2018)引用 149|浏览17暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要